The US Food and Drug Administration has pulled accreditation for the third-party reviewer Accelerated Device Approval Services (ADAS) because the agency says the company lied to a sponsor about a nonexistent reviewer and its communications with regulators.
The FDA warned ADAS on 12 March it planned to pull the company’s accreditation after it emerged that the...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?